Public Assessment Reports - All: Mirtazapine 15mg, 30mg and 45mg Orodispersible Tablets (PL 21880/0107-9)
|
|---|
|
The following section/document has been added/updated |
|
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your subscriber preferences page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com. All other enquiries can be directed to email.support@mhra.gsi.gov.uk. This is an automatically generated email. Please do not reply directly to this notification. This service is provided to you at no charge by the MHRA. Medicines and Healthcare products Regulatory Agency |
|
This email has been sent to Email Address because you are subscribed to the MHRA Public Assessment Reports - All email channel. |
 |